Thompson Rahsaan

Track

Insider profile

Thompson Rahsaan's trades of Zevra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
177.05
Quantity 13,303 -49.2%
Value US$4,316,930
Transaction date
Proposed sale
Price
321.82
Quantity 28,460
Value US$2,887,324
Transaction date
Planned sale
Price
442.54
Quantity 25,302 +7.6%
Value US$4,793,621
Transaction date
Proposed sale
Price
8.86
Quantity 4,080
Value US$36,149
Transaction date
Proposed sale
Price
9.33
Quantity 24,000
Value US$223,920
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-14
PlS Planned sale
13,303 -49.2%
177.05
US$4,316,930 		13,303 -49.2% 177.05 US$4,316,930
2026-08-14 2026-08-14
PrS Proposed sale
28,460
321.82
US$2,887,324 		28,460 321.82 US$2,887,324
2026-06-23 2026-06-22
PlS Planned sale
25,302 +7.6%
442.54
US$4,793,621 		25,302 +7.6% 442.54 US$4,793,621
2026-05-13 2026-05-11
PlS Planned sale
1,794 -3.6%
11.30
US$20,272 		1,794 -3.6% 11.30 US$20,272
2026-05-11 2026-05-11
PrS Proposed sale
36,351
11.13
US$404,587 		36,351 11.13 US$404,587
2026-02-02 2026-01-30
PlS Planned sale
4,080 -7.6%
8.83
US$36,010 		4,080 -7.6% 8.83 US$36,010
2026-01-30 2026-01-30
PrS Proposed sale
4,080
8.86
US$36,149 		4,080 8.86 US$36,149
2025-06-30 2025-06-26
PlS Planned sale
24,000 -36.0%
9.21
US$221,004 		24,000 -36.0% 9.21 US$221,004
2025-06-26 2025-06-26
PrS Proposed sale
24,000
9.33
US$223,920 		24,000 9.33 US$223,920